Platinum-derivatized homopyrimidine triplex-forming
oligonucleotides (Pt-TFOs) consisting of 2'-O-methyl-5-methyluridine, 2'-O-methyl-5-methylcytidine, and a single 3'-N7-trans-chlorodiammine platinum(II)-2'-deoxyguanosine were designed to cross-link to the transcribed strand at four different sequences in the human
androgen receptor (AR) gene. Fluorescence microscopy showed that a
fluorescein-tagged Pt-TFO localizes in both the cytoplasm and nucleus when it is transfected into LAPC-4 cells, a human
prostate cancer cell line, using
Lipofectamine 2000. A capture assay employing
streptavidin-coated magnetic beads followed by polymerase chain reaction (PCR) amplification was used to demonstrate that 5'-biotin-conjugated Pt-TFOs cross-link in vitro to their four designated AR gene targets in genomic
DNA extracted from LAPC-4 cells. Similarly, the capture assay was used to examine cross-linking between the 5'-biotin-conjugated Pt-TFOs and the AR gene in LAPC-4 cells in culture. Three of the four Pt-TFOs cross-linked to their designated target, suggesting that different regions of the AR gene are not uniformly accessible to Pt-TFO cross-linking. LAPC-4 cells were transfected with
fluorescein-tagged Pt-TFO or a control
oligonucleotide that does not bind or cross-link to AR
DNA. The levels of AR
mRNA in highly fluorescent cells isolated by fluorescence-activated cell sorting were determined by RT-qPCR, and the levels of AR
protein were monitored by immunofluorescence microscopy. Decreases in
mRNA and
protein levels of 40 and 30%, respectively, were observed for
fluorescein-tagged Pt-TFO versus control treated cells. Although the levels of knockdown of AR
mRNA and
protein were modest, the results suggest that Pt-TFOs hold potential as agents for controlling gene expression by cross-linking to
DNA and disrupting transcription.